Fred Hassan Elected to Time Warner (TWX) Board of Directors
More News related to TWX
- Multi-Talented Singing Sensation Justin Bieber to Join Mary J. Blige, Neil Diamond, Sugarland, Rob Thomas and Usher in TNT's CHRISTMAS IN WASHINGTON, Hosted by George Lopez
- Time Warner Cable Delivers Fastest Wireless Speeds Available to Dallas Area Customers With the Launch of an All New 4G Wireless Data Service
- NTDTV Available 24/7 On Time Warner Cable In NYC
- Time Warner (TWX) volatility at 33 into spin-off of AOL
- Collins Stewart Maintains a 'Buy' Rating on Time Warner (TWX); Raises PT & Estimates
More News related to Management Changes
- A.C. Moore (ACMR) Hires Richard Arthur as VP of Marketing and Advertising
- Cascade Microtech's (CSCD) CEO, Wild, to Resign
- Qualcomm (QCOM) Appoints Rich Sulpizio to President and CEO of QCOM Enterprise Services
- ConocoPhillips (COP) Promotes Larry Archibald to SVP, Exploration and Business Development
- GM's Chairman, Ed Whitacre, has said that the search for a CEO could take as long as a year
Time Warner Inc. (NYSE: TWX) announced that its Board of Directors has elected Fred Hassan to join the Board, effective today. Mr. Hassan, 63, is Chairman of the Board and Chief Executive Officer of Schering-Plough Corporation.
Mr. Hassan became Chairman and CEO of Schering-Plough Corporation in 2003. Before joining Schering-Plough, he served as CEO (from 2000 to 2001) and as Chairman and CEO (from 2001 to 2003) of Pharmacia Corporation until the company was acquired by Pfizer Inc. in 2003. From 1997 to 2000, Mr. Hassan was CEO of Pharmacia & Upjohn, Inc., which merged with Monsanto Company in 2000 to become Pharmacia Corporation. From 1972 to 1997, he served in various senior management roles at major pharmaceutical companies.
Mr. Hassan received a B.S. degree from the Imperial College of Science and Technology at the University of London and an M.B.A. degree from Harvard Business School.
Related Categories
Management ChangesStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
